CardiovascularResearch Phase

Urocortin 2

Intravenous

Overview

Urocortin 2 is a 38-amino acid peptide member of the corticotropin-releasing factor family with selective affinity for CRF receptor 2. It exerts cardiovascular effects including coronary and peripheral vasodilation, increased cardiac contractility, and protection against ischemia-reperfusion injury through receptor-mediated cyclic AMP signaling.

Mechanism of Action

The selective receptor profile distinguishes it from urocortin 1 and may offer advantages in minimizing stress-axis activation..

Research Summary & Key Findings

Preclinical studies in animal models have demonstrated that urocortin 2 improves cardiac output and reduces myocardial injury in heart failure and ischemia models. Limited early-phase human data exist, and the peptide remains in the research phase without published clinical efficacy trials for cardiovascular indications.

Clinical Status

Research Phase

Urocortin 2 is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

Intravenous

Related Peptides in Cardiovascular

Eptifibatide (Integrilin)

FDA Approved

A synthetic cyclic heptapeptide modeled after the KGD (Lys-Gly-Asp) disintegrin sequence found in the venom of the south...

View details

Nesiritide (Natrecor)

FDA Approved

A recombinant form of human B-type natriuretic peptide (BNP), a 32-amino acid peptide naturally produced by ventricular ...

View details

Angiotensin II (Giapreza)

FDA Approved

A synthetic form of the endogenous octapeptide angiotensin II, the primary effector of the renin-angiotensin system. Ang...

View details

Serelaxin (Relaxin-2)

Investigational

Serelaxin is a recombinant form of human relaxin-2, a naturally occurring peptide hormone composed of two chains linked ...

View details

Find a Provider

Find a verified provider who offers Urocortin 2 therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Urocortin 2.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.